Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June ...

The company is planning manufacturing footprint changes, supply chain adjustments, surcharges and cost cutting to limit the ...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board ...

Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart ...

The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of ...

CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend ...

The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity ...

Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and ...

The cuts to the FDA are just one piece of the budget proposal, which looks to slash the HHS’ discretionary spending by ...

Former Avanos Medical executive Michael Greiner has left the company. Greiner was CFO and chief transformation officer at the pain and nutrition company before becoming interim CEO in October. However ...